PG
AZN icon

PEAK6 Group’s AstraZeneca AZN Stock Holding History

PEAK6 Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$9.94M Buy
141,550
+116,550
+466% +$8.38M 0.04% 447
2018
Q1 		$1.75M Sell
25,000
-97,250
-80% -$6.74M 0.01% 1490
2017
Q4 		$8.48M Sell
122,250
-60,300
-33% -$4.07M 0.04% 549
2017
Q3 		$12.4M Buy
182,550
+163,150
+841% +$10.3M 0.06% 323
2017
Q2 		$1.32M Sell
19,400
-124,600
-87% -$8.14M 0.01% 1693
2017
Q1 		$8.97M Sell
144,000
-13,650
-9% -$795K 0.07% 321
2016
Q4 		$8.61M Buy
157,650
+121,550
+337% +$6.9M 0.06% 425
2016
Q3 		$2.37M Sell
36,100
-66,850
-65% -$4.37M 0.02% 1161
2016
Q2 		$6.22M Buy
102,950
+49,300
+92% +$2.86M 0.05% 552
2016
Q1 		$3.02M Buy
53,650
+11,400
+27% +$685K 0.02% 906
2015
Q4 		$2.87M Sell
42,250
-112,250
-73% -$7.36M 0.02% 1073
2015
Q3 		$9.83M Buy
154,500
+86,500
+127% +$5.69M 0.05% 481
2015
Q2 		$4.33M Buy
68,000
+55,400
+440% +$3.79M 0.03% 920
2015
Q1 		$862K Buy
+12,600
New +$875K 0.01% 2027
2014
Q4 		– Sell
-45,500
Closed -$3.25M – 4642
2014
Q3 		$3.25M Buy
45,500
+36,800
+423% +$2.69M 0.03% 905
2014
Q2 		$646K Sell
8,700
-2,000
-19% -$145K 0.01% 2061
2014
Q1 		$694K Sell
10,700
-136,400
-93% -$8.81M 0.01% 2219
2013
Q4 		$8.73M Sell
147,100
-106,100
-42% -$5.76M 0.06% 389
2013
Q3 		$6.58M Buy
253,200
+95,900
+61% +$4.82M 0.05% 568
2013
Q2 		$7.44K Buy
+157,300
New +$8.01M 0.03% 469

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PEAK6 Group's AZN Position: Q2 2018 in Review

PEAK6 Group sold out of AstraZeneca (AZN) in Q2 2018, closing a stake of 24,574 shares — an estimated $1.77M sold.

PEAK6 Group first reported a position in AZN in Q1 2014 and held it in 13 quarters. The position peaked at $10.6M in Q3 2015. 530 funds tracked by Wall St. Rank hold AZN as of Q2 2018.

  • PEAK6 Group reported no remaining AstraZeneca position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 24,574 AstraZeneca shares in Q2 2018, an estimated $1.77M.
  • PEAK6 Group first reported a position in AstraZeneca in Q1 2014 and held it in 13 quarters.
  • PEAK6 Group's AstraZeneca position peaked at $10.6M in Q3 2015.
  • 530 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.